AlanMMillerMDPhD

PubMed

• 18 citations
  Outcome of Lower-Intensity Allogeneic Transplantation in Non-Hodgkin Lymphoma after Autologous Transplantation Failure
  Cesar O. Freytes, Mei-Jie Zhang, Jeanette Carreras, Linda J. Burns, Robert Peter Gale
  Biology of Blood and Marrow Transplantation. 2012-08-01
• 99 citations
  Ph+ ALL patients in first complete remission have similar survival after reduced intensity and myeloablative allogeneic transplantation: impact of tyrosine kinase inhi...
  Veronika Bachanova, David I. Marks, Mei-Jie Zhang, Hai-Lin Wang, M. de Lima
  Leukemia. 2014-03-01
• 93 citations
  Autotransplants for Hodgkin's disease in first relapse or second remission: a report from the autologous blood and marrow transplant registry (ABMTR)
  Hillard M. Lazarus, Fausto R. Loberiza, Mei-Jie Zhang, James O. Armitage, Karen K. Ballen
  Bone Marrow Transplantation. 2001-02-01

Journal Articles

• Effect of Postremission Therapy before Reduced-Intensity Conditioning Allogeneic Transplantation for Acute Myeloid Leukemia in First Complete Remission  
  Warlick ED, Paulson K, Brazauskas R, Zhong X, Miller AM, Camitta BM, George B, Savani BN, Ustun C, Marks DI, Waller EK, Baron F, Freytes CO, Socie G, Akpek G, Schouten..., Biology of Blood Marrow Transplantation, 2/1/2014
• Providing personalized prognostic information for adult Leukemia survivors  
  Lee SJ, Storer B, Wang H, Lazarus HM, Waller EK, Isola LM, Klumoo TR, Umejiego JBC, Savani BN, Loren AW, Cairo MSCamitta BM, Cutler CS, George B, Khoury HJ, Marks DI, ..., Biology of Blood and Marrow Transplantation, 11/19/2013
• Reduced Intensity Hematopoietic Cell Transplantation for Patients with Primary Myelofibrosis: ACohort Analysis from the Center for International Blood and Marrow Trans...  
  Gupta V, K. Malone AK, Hari PN, Ahn KW, Hu ZH, Gale RP, Ballen KK, Hamadani M, Olavarria E, Gerds AT, Waller EK, Costa LJ, Antin JH, Kamble RT, van Besien KM, Savani B..., Biology and Marrow Transplantation, 10/23/2013
• PH+ all patientsin first remission have similar survival after reduced intensity and myeloablative allogeneic transplantation: Impact of imatinib and minimal residual ...  
  Bachanova V, Marks DI, Zhang MJ, Wang H, Lima Md, Aljurf MD, Arellano M, Artz AS, Bacher U, Cahn JY, Chen YB, Coplelan EA, Drobyski WR, Gale RP, Greer JP, Gupta V, Hal..., Leukemia, 8/30/2013
• Advance care planning knowledge and documentation in a hospitalized cancer population  
  Barakat A, Barnes SA, Casanova MA, Stone MJ, Shuey KM, Miller AM, Baylor Proceedings, 1/1/2013
• Model for the cost-efficient delivery of continuous quality cancer care: A hospital and private practice collaboration  
  Coyle YM, Miller, AM, Paulson, RS, Baylor Proceedings, 1/1/2013
• Outcome of Lower-Intensity Allogeneic Transplantation in Non-Hodgkin Lymphoma after Autologous Transplantation Failure  
  Freytes CO, Zhang MJ, Carreras J, Burns LJ, Gale RP, Isola L, Perales MA, Seftel M, Vose JM, Miller AM, GibsonJ, Gross TG, Rowlings PA, Inwards DJ, Pavlovsky S, Martin..., Biol Blood Marrow Transplant, 1/1/2012
• Classifying cytogenetics in patients with acute myelogenous leukemia in complete remission undergoing allogeneic transplantation: a Center for International Blood and ...  
  Armand P, Kim HT, Zhang MJ, Perez WS, Dal Cin PS, Klumpp TR, Waller EK, Litzow MR, Liesveld JL, Lazarus HM, Artz AS, Gupta V, Savani BN, McCarthy PL, Cahn JY, Schouten..., Biol Blood Marrow Transplant, 1/1/2012
• Influence of Age and History on Outcome in Adult Non-Hodgkin Lymphoma Patients Undergoing Autologous Hematopoietic Cell Transplantation (HCT): A Report from The Center...  
  Lazarus HM, Carreras J, Boudreau C, Loberiza FR, Armitage JO, Bolwell BJ, Freytes CO, Gale RP, Gibson J, Hale GA, Inwards DJ, LeMaistre CF, Maharaj D, Marks DI, Miller..., Transplantation, 1/1/2008
• A comparison of allogeneic and autologous bone marrow transplantation for lymphoblastic lymphoma  
  Levine JE, Harris RE, Loberiza FR Jr, Armitage JO, Vose JM, Van Besien K, Lazarus HM, Horowitz MM, Bushey A, Bolwell BJ, Burns LJ, Cairo MS, Champlin RE, Freytes CO, G..., Blood, 1/1/2003
• Neuronal stem cells biology and plasticity  
  LaRussa V, Dubasis M, Miller AM, Safah H, Rozans M, Curiel T, Agrawal K, Weiner R, Cancer Investigation, 1/1/2003
• Stem cell transplantation for the treatment of refractory lupus nephritis  
  Miller AM, Scott JW, Show Chwan Medical Journal, 1/1/2002
• Marrow stem cells, mesenchymal progenitor cells, and stromal progeny  
  LaRussa V, Schwartzenberger P, Miller AM, Agrawal K, Kolls J, Weiner R, Cancer Investigation, 1/1/2002
• Resolution of chronic thrombocytopenia purpura following syngeneic peripheral blood progenitor transplant Case Report  
  Zayden MD, Turner C, Miller AM, Bone Marrow Transplantation, 1/1/2002
• Autotransplants for Hodgkin’s disease in first relapse or second remission: A report from the Autologous Blood and Marrow Transplant Registry (ABMTR)  
  Lazarus HM, Loberiza FR Jr, Zhang MJ, Aritage JO, Ballen KK, Bashey A, Bolwell BJ, Burns LJ, Freytes CO, Gale RP, Gibson J, Herzig RH, LeMaistre CF, Marks D, Mason J, ..., Bone Marrow Transplantation, 1/1/2001
• Use of PEG-rHuMGDF in platelet engraftment after autologous stem cell transplantation  
  Fields KK, Crump M, Bence-Bruckler I, Bernstein S, Williams S, Frankel S, Miller A, Demetri G, Nabholtz JM, Cruickshank S, Lill M, Bone Marrow Transplantation, 1/1/2000
• Decreased quality of peripheral blood progenitors collected after a peripheral blood progenitor transplant  
  Miller A, Morrison D, Safah H, Cullins S, LaRussa V, Rink J, Weiner R, Journal of Hematotherapy and Stem Cell Research, 1/1/2000
• Exacerbation of bleomycin-induced lung injury in mice by amifostine  
  Ortiz LA, Lasky JA, Safah H, Reyes M, Miller AM, Lungarella G, Friedman M, American Journal of Physiology, 1/1/1999
• Limited erythropoietic response to combined treatment with recombinant human IL-3 and erythropoietin in myelodysplastic syndrome  
  Miller AM, Noyes WE, Taetle R, List AF, Leukemia Research, 1/1/1999
• Durable remission of locally advanced breast cancer with multimodality management  
  Miller AM, Khosla P, Lynch J, Moreb J, Cullins S, Safah Hutcheson C, LaRussa V, Vellis K, Rice J, Mendenhall N, Weiner R, Medical Oncology, 1/1/1998
• Interleukin 17 stimulates hematopoiesis in mice via expansion of the hematopoietic progenitor pool  
  Schwarzenberger P, LaRussa V, Miller AM, Peng Y, Hugan W, Zieske A, Mynatt R, Spriggs M, Kolls JK, Journal of Immunology, 1/1/1998
• Chronic myelogenous leukemia and porphyria cutanea tarda in a patient with limited systemic sclerosis  
  Wooten M, Scott JW, Miller AM, Boh E, Southern Medical Journal, 1/1/1998
• Toxicity associated with high-dose cytosine arabinoside and total body irradiation as conditioning for allogeneic bone marrow transplantation  
  Kumar M, Saleh A, Rao PV, Ochoa S, Meyers L, Miller AM, Graham-Pole J, Bone Marrow Transplantation, 1/1/1997
• Frequency of BCL-2/JH translocation in peripheral blood of follicular lymphoma patients  
  Zhang X-Y, Safah H, Mudad R, Maher E, Krause J, Miller AM, Ehrlich M, American Journal of Hematology, 1/1/1997
• Lipoxygenase metabolism is required for interleukin-3 dependent proliferation and cell cycle progression of the human M-07e cell line  
  Miller AM, Allen B, Journal of Cellular Physiology, 1/1/1997
• Join now to see all

Books/Book Chapters

• Prostaglandins, Leukotrienes, Lipoxins, and PAF: Mechanism of Action, Molecular Biology, and Clinical Applications 
  Chapter: Lipoxygenase metabolism in the regulation of hematopoiesis. 
  Page 339 - 351Miller AMEditors: JM Bailey.Plenum Publishing Corp, New York1991
• Experimental Hematology Today '88 
  Chapter: Alterations in dependence on lipoxygenase metabolism in myeloid leukemia. 
  Page 140 - 146Miller AM, Cullen MK, Kobb SM, Weiner RSEditors: Baum S.Springer-Verlag, New York1989
• Hematopoiesis. Long-Term Effects of Chemotherapy and Radiation 
  Chapter: Long-term bone marrow damage after acute nonlymphocytic leukemia. 
  Page 289 - 300Miller AM, Weiner RSEditors: Testa NG, Gale RP.Marcel Dekker, Inc., New York1988
• Maturation Factors 
  Chapter: Colony stimulating factor. 
  Page 209 - 247Yunis AA, Wu M-C, Miller AMEditors: G. Guroff.John Wiley & Sons, Inc., New York1983
• Prostaglandins and Cancer: First International Conference 
  Chapter: Evidence for involvement of the lipoxygenase pathway in CSF-induced human and murine myeloid colony formation. 
  Page 481 - 485Miller AM, Ziboh VA, Yunis AAEditors: Powles TJ, Bockman RS, Honn KV, Ramwell P.Alan J. Liss, Inc., New York1982
• Proceedings of the Conference of Aplastic Anemia. A Stem Cell Disease. 
  Chapter: On the mechanisms of a plastic anemia of chloramphenicol. 
  Yunis AA, Miller AM, Corbett MD, Salem ZNIH, San Francisco, CA1981
• Diffusion Chamber Culture 
  Chapter: The use of diffusion chambers in the study of tumor immunobiology and lymphokines. 
  Page 234 - 241Buessow S, Lopez DM, Miller AMEditors: Cronkite EP, Carsten AL.Springer-Verlag, Berlin1980
• Diffusion Chamber Culture 
  Chapter: The use of diffusion chambers in studying cell interactions: Sequential studies of eosinophil granulopoiesis in vivo. 
  Page 139 - 149Miller AM, McGarry MPEditors: Cronkite EP, Carsten AL.Springer-Verlag, Berlin1980
• Experimental Hematology Today 
  Chapter: Humoral regulation of eosinophil granulocytopoiesis. 
  Page 63 - 70McGarry MP, Miller AM, Colley DGEditors: Baum S.Springer-Verlag1977
• Join now to see all

Abstracts/Posters

• Weekly Bortezomib For The Treatment of Steroid Refractory Chronic Graft Versus Host Disease (CGVHD).
  Miller, AM, Schneider, R, Agura, EA, Vance, E, Berryman, RB, Fay, J, Pineiro, L., Powell, S, Tadic Ovcina, M,Sampson, CA, Baylor Charles A. Sammons Cancer Center, Dall..., Biology of Blood and Marrow Transplantation. ASBMT, 2/1/2011
• A combined FISH-immunoflourescence technique with high specificity to the short arm of the Y chromosome in rhesus monkey tissues.
  Xia X, Rasmusen T, Alvarez X, Taguchi T, Li M, Hemenway C, Miller AM, Weiner R, LaRussa VF, Experimental Hematology, 1/1/2006
• Long-term culture system for mesenchymal colony forming cells (M-CFC).
  LaRussa VF, Lee M, Price S, Safah H, Miller AM, Rozans M, Weiner R, ISEH, Tutorial, New Orleans, 7/1/2004
• The Dead Sea Scrolls: A previously unreported randomized trial of autologous bone marrow transplant, Circa 1958.
  Miller AM, Sprague CC, Krementz ET, Experimental Hematology, 1/1/2004
• Engraftment and long-term production of mesenchymal colony forming cells in vitro.
  LaRussa VF, Price S, Miller AM, Safah H, Rozans M, Weiner R, Experimental Hematology, Paris, 1/1/2003
• Engraftment and production of mesenchymal colony forming cells (M-CFC) in vitro.
  LaRussa VF, Lee M, Price S, Safah H, Miller AM, Rozans M, Weiner R, BBMT, 1/1/2003
• Immunoablative transplantation for lymphoid malignancies.
  Briggs A, Safah H, List A, Epner E, Weiner R, Rink J, Miller AM, BBMT, 1/1/2002
• CD34+ cell derived BLAST cell nesting sites on adipogenic and mon-adipogenic mesenchymal cell colonies correlate with production of hematopoietic progenitor cells.
  LaRussa VF, Alzoebie A, Schwarzenberger P, Price A , Scher C, Miller AM, Safah H, Rozans M, Kolls J, Weiner R, Blood 100, 1/1/2002
• Engraftment and long-term production of mesenchymal colony forming cells in vitro.
  LaRussa VF, Lee M, Price S, Miller AM, Safah H, Rozans M, Weiner R, Blood 100, 1/1/2002
• IL-17 increases the engraftment potential of highly purified CD34+ cells on individual stromal colonies.
  Weiner R, Alzoebie A, Schwartzenburger P, Miller AM, Safah H, Rozans M, Scher C, Warrier R, Kolls J, LaRussa VF, ASBMT; Biology of Blood Marrow Transplantation, 2/1/2001
• Amifostine protects human clonogenic mesenchymal progenitor cells exposed to radiation.
  LaRussa VF, Ramdas J, Miller AM, Warrier R, Scher C, Weiner R, ISHAGE, 1/1/2001
• Self renewal potential of mesenchymal colony forming cells from human bone marrow.
  LaRussa VF, Price S, Miller AM, Safah H, Rozans M, Weiner R, Blood 98, 1/1/2001
• Engraftment and production of mesenchymal colony forming cells in vitro.
  LaRussa VF, Price S, Miller AM, Safah H, Rozans M, Weiner R, Blood 98, 1/1/2001
• IL-17 enhances cobblestone area formation of highly purified CD34+ cells on individual mesenchymal/stromal progenitor derived stromal cell colonies.
  LaRussa V, Schwartzenberger P, Miller AM, Kohls J, Scher C, Warrier R, Weiner R, Alzobie A, Blood 96, 1/1/2000
• IL-17 priming increases the engraftment potential of highly purified CD34+ hematopoietic stem cells on individual mesenchymal/stromal progenitor derived stromal cell c...
  LaRussa V, Schwartzenberger P, Miller AM, Kohls J, Scher C, Warrier R, Weiner R, Alzobie A, Blood 96, 1/1/2000
• Autologous stem cell transplantation for lymphoma using Stamp V conditioning regimen.
  Khan S, Lynch J, Boyette R, Reddy V, Finiewicz K, Zayden M, Miller AM, Oblon D, Moreb J, Wingard J, Blood 96, 1/1/2000
• Join now to see all

Other

• Eosinophilopoiesis stimulating factor (EoSF): An immune dependent diffusible granulopoietin [Doctoral dissertation]. 
  Miller AM, SUNY
  Buffalo, NY - 1/1/1976